Shares of C.R. Bard (BCR) Sees Large Inflow of Net Money Flow

C.R. Bard (BCR) : On Friday, The money flowed into the C.R. Bard (BCR) stock with an uptick to downtick ratio was recorded at 1.36. Transactions worth $33.53 million were done on upticks, confirming the buying interest in the stock. The outflow of money on downticks stood at $24.71 million. The total money flow into the stock was $8.82 million. The investors are using every small weakness in the stock to accumulate it, as can be seen in the $10.87 million of block transactions on upticks. The total money flow in block trades was $10.87 million. In terms of price action, C.R. Bard (BCR) traded down $1.45 during the session at $230. Compared to the previous days closing, the stock was down only by -0.63%. For the week, the stock is -0.96%, over previous weeks closing.


C.R. Bard (BCR) : The highest level C.R. Bard (BCR) is projected to reach is $250 for the short term and the lowest estimate is at $215. The consolidated price target from 9 rating analysts who initiate coverage on the stock is $232.67 and the possibility the share price can swing is $11.63.

C.R. Bard (NYSE:BCR): On Fridays trading session , Opening price of the stock was $230.75 with an intraday high of $231.18. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $228.34. However, the stock managed to close at $230, a loss of 0.63% for the day. On the previous day, the stock had closed at $231.45. The total traded volume of the day was 524,766 shares.

In a related news, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the officer (Senior Vice President and CFO) of Bard C R Inc /Nj/, Holland Christopher S had sold 3,970 shares worth of $872,924 in a transaction dated May 27, 2016. In this transaction, 3,970 shares were sold at $219.88 per share.

C. R. Bard, Inc. (Bard) and its subsidiaries are engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. . The Company reports its sales in four major product group categories: vascular, urology, oncology and surgical specialty. The Company also has a product group of other products. The Companys vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and heart arrhythmias. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and other soft tissue repairs, in addition to hemostats and surgical sealants.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.